FN1 and idiopathic pulmonary fibrosis: In a study of IPF fibroblasts, Knüppel et al. found nintedanib to reduce gene expression of type I collagen and fibronectin and attenuate the secretion of type I and III collagen, whereas pirfenidone showed less pronounced effects even in concentrations of up to 1000 μM [48].